BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3982561)

  • 21. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Telomerase activity in human gastric and colorectal cancer].
    Chen W; Zhang Q; Wan D
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):261-3. PubMed ID: 10920978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of serum-5-nucleotidase, alkaline phosphatase and gamma-glutamyl transferase for prediction of liver metastases preoperatively in colorectal cancer.
    Jönsson PE; Bengtsson G; Carlsson G; Jonson G; Tryding N
    Acta Chir Scand; 1984; 150(5):419-23. PubMed ID: 6148827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathepsin B in the growth of colorectal cancer: increased activity of cathepsin B in human colorectal cancer.
    Satoh Y; Higashi T; Nouso K; Shiota T; Kinugasa N; Yoshida K; Uematsu S; Nakatsukasa H; Nishimura Y; Tsuji T
    Acta Med Okayama; 1996 Dec; 50(6):305-11. PubMed ID: 8985467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
    Tumminello FM; Flandina C; Crescimanno M; Leto G
    Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapy.
    Topolcan O; Holubec L; Finek J; Stieber P; Holdenrieder S; Lamerz R; Holubec Sen L; Svobodova S; Visokai V; Lipska L
    Anticancer Res; 2005; 25(3A):1831-3. PubMed ID: 16033109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomerase activity associated with acquisition of malignancy in human colorectal cancer.
    Chadeneau C; Hay K; Hirte HW; Gallinger S; Bacchetti S
    Cancer Res; 1995 Jun; 55(12):2533-6. PubMed ID: 7780964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alcohol dehydrogenase and aldehyde dehydrogenase as tumour markers and factors intensifying carcinogenesis in colorectal cancer].
    Jelski W; Orywal K; Kedra B; Szmitkowski M
    Pol Merkur Lekarski; 2008 Jun; 24(144):506-10. PubMed ID: 18702331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
    Wagner T; Peschel U; Heydrich D; Ritter U
    Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
    Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
    Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
    Kos J; Nielsen HJ; Krasovec M; Christensen IJ; Cimerman N; Stephens RW; Brünner N
    Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer.
    Zore I; Krasovec M; Cimerman N; Kuhelj R; Werle B; Nielsen HJ; Brünner N; Kos J
    Biol Chem; 2001 May; 382(5):805-10. PubMed ID: 11517934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase activity and p53 gene mutation in familial polyposis coli.
    Ikeguchi M; Makino M; Kaibara N
    Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.
    Kruszewski WJ; Rzepko R; Wojtacki J; Skokowski J; Kopacz A; Jaśkiewicz K; Drucis K
    Neoplasma; 2004; 51(1):38-43. PubMed ID: 15004658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.
    Yokoyama S; Shatney CH; Mochizuki H; Hase K; Johnson DL; Cummings S; Trollope ML; Tamakuma S
    Am Surg; 1997 Mar; 63(3):243-6; discussion 246-7. PubMed ID: 9036892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression.
    Miyake H; Hara I; Eto H
    Anticancer Res; 2004; 24(4):2573-7. PubMed ID: 15330217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small colorectal polyps: histopathology and clinical significance.
    Tsai CJ; Lu DK
    Am J Gastroenterol; 1995 Jun; 90(6):988-94. PubMed ID: 7771436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cooperative study on the detection of colorectal cancer and polyps in France.
    Martin F; Poynard T; Ribet A; Escourrou J; Delpu J; Klepping C; Bernier JJ; Soullard J; Marti R; Nisard A; Bader JP; Sarles H; Sahel J; Bonfils S; Vilotte J; Grenier J; Loygue J; Flamant R
    Cancer Detect Prev; 1981; 4(1-4):407-15. PubMed ID: 7349802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.